Skip to main content

Sofinnova Partners — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

150
Companies
$7.1B
Total invested
$47.4M
Avg. check
32
Industries
Biotechnology 14Health Care 8Therapeutics 7Medical 5Software 5Artificial Intelligence (AI) 4+26 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 150
Purespring Therapeutics
October 2024

Purespring Therapeutics is a gene therapy company that provides treatments for different kidney diseases.

Biotechnology · London$104.5M Series B
Micropep Technologies
September 2024

Micropep Technologies is a biotech company that focused on biological alternatives to agrochemicals.

Agriculture · Ramonville-saint-agne$11.0M Series B
Genespire
September 2024

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.

Biotechnology · Milan$52.2M Series B
Arzeda
September 2024

Arzeda is a protein design company that creates and manufactures proteins and enzymes for pharmaceuticals and industrial chemicals.

Artificial Intelligence (AI) · Seattle$38.0M Series C
NOVAMEAT
September 2024

NOVAMEAT develops cutting-edge technological solutions to feed the planet's growing population with plant-based foods.

Alternative Protein · Barcelona$19.3M Series A
deepc
July 2024

The AI Operating System for the Future of Radiology

Artificial Intelligence (AI) · Munich$13.0M Series A
Asceneuron
July 2024

Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

Biotechnology · Lausanne$100.0M Series C
Myricx Bio
July 2024

Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.

Biotechnology · London$115.3M Series A
CorVent Medical
June 2024

We provide simple, sophisticated respiratory solutions for post-ICU and home environments, eliminating unnecessary cost and complexity.

Health Care · Fargo$3.0M Grant
May Health
May 2024

May Health develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility.

Health Care · Paris$24.8M Series B
Cure51
March 2024

Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features.

Biotechnology · Paris$16.3M Seed
Hookipa Pharma
December 2023

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

Biotechnology · New York$14.4M Post-IPO Equity
Inotrem
November 2023

Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.

Biotechnology · ParisVenture - Series Unknown
l'école
October 2023

l'école AI is a computer vision-focused development platform.

Artificial Intelligence (AI) · New York$3.0M Seed
Betteromics
October 2023

BetterOmics is a SaaS platform that empowers professionals in the life sciences industry with cutting-edge AI and computational techniques.

Analytics · Redwood City$20.0M Series A
Sitryx Therapeutics
September 2023

Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Biotechnology · Oxford$39.0M Series A
Aledia
September 2023

Aledia develops and manufactures innovative light-emitting diodes (LEDs) based on a unique 3D architecture.

Hardware · Grenoble$128.0M Venture - Series Unknown
Gradient Denervation Technologies
September 2023

Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension.

Biotechnology · Paris$15.0M Series A
Corwave
June 2023

CorWave is a medical device company developing innovative heart pumps.

Health Care · Paris$28.4M Series C
Mozart Therapeutics
June 2023

Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.

Biotechnology · Seattle$25.0M Series A
Werewool
May 2023

Werewool develops a fiber development platform to create biodegradable fibers.

Industrial · New York$3.7M Seed
Alia Therapeutics
April 2023

Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.

Biotechnology · Trento$4.8M Seed
BioCorteX
March 2023

Capturing the human-bacterial relationship to address the seemingly impossible question - will this drug work [for me?]

Biotechnology · London$5.0M Seed
Kiro
March 2023

Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.

Artificial Intelligence (AI) · Paris$15.0M Series A

Where Sofinnova Partners invests

Biotechnology14
Health Care8
Therapeutics7
Medical5
Software5
Artificial Intelligence (AI)4

About Sofinnova Partners's portfolio

How many companies has Sofinnova Partners invested in?▸

Sofinnova Partners has invested in 150 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Sofinnova Partners invest in?▸

Sofinnova Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Software. The firm invests across 32 different industry categories.

What is Sofinnova Partners's largest investment?▸

Among tracked funding rounds, Aledia received $128.0M in a Venture - Series Unknown round. Sofinnova Partners's total known invested capital is $7.1B.

What is the average investment size for Sofinnova Partners?▸

Sofinnova Partners's average investment size is $47.4M across its portfolio of 150 companies.

What are Sofinnova Partners's most recent investments?▸

Recent Sofinnova Partners portfolio additions include Purespring Therapeutics, Micropep Technologies, Genespire, Arzeda, NOVAMEAT. These companies were founded in 2020 or later.

Reach the founders behind these 150 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →